SEC Form D · filed March 7, 2023
Enveda Therapeutics, Inc
Offering
$62.5M
Sold
$62.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boulder, CO
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗